Company · CIK 0001746466 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Equillium, Inc. · EQ
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 SForm 4 → | Jun 5, 4:42 pm EDT | Christine ZedelmayerSr. Vice President and COO | 14,584 | $2.93 | $42,737 | 62,586 | −18.9% | 10b5-1 |
| Jun 5, 2026 MForm 4 → | Jun 5, 4:42 pm EDT | Christine ZedelmayerSr. Vice President and COO | 14,584 | $0.785 | $11,448 | 77,170 | — | 10b5-1 |
| Jun 4, 2026 SForm 4 → | Jun 5, 4:42 pm EDT | Stephen ConnellyPresident and CSO | 230,975 | $3.13 | $723,830 | 762,025 | −23.3% | |
| Oct 16, 2018 JForm 4 → | Oct 16, 5:51 pm EDT | Bruce D. SteelPresident, CBO, Director | 48,495 | $11.20 | $543,144 | 48,495 | — | plan? |
| Oct 16, 2018 JForm 4 → | Oct 16, 5:39 pm EDT | Daniel BradburyChief Executive Officer, Director | 48,495 | $11.20 | $543,144 | 2,969,596 | — | plan? |
| Oct 16, 2018 AForm 4 → | Oct 16, 5:35 pm EDT | Biocon SA10% Owner | 228,060 | — | — | 2,316,134 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 MForm 4 → | Jun 5, 4:42 pm EDT | Christine ZedelmayerSr. Vice President and COO | 14,584 | — | — | 25,521 | — | 10b5-1 |
| Feb 13, 2019 AForm 4 → | Feb 15, 6:23 pm EST | Jason A KeyesChief Financial Officer | 70,000 | — | — | 70,000 | — | |
| Feb 13, 2019 AForm 4 → | Feb 15, 6:22 pm EST | Stephen ConnellyChief Scientific Officer, Director | 90,000 | — | — | 90,000 | — | |
| Feb 13, 2019 AForm 4 → | Feb 15, 6:21 pm EST | Krishna R PoluChief Medical Officer | 90,000 | — | — | 90,000 | — | |
| Feb 13, 2019 AForm 4 → | Feb 15, 6:18 pm EST | Bruce D. SteelPresident, CBO, Director, 10% Owner | 90,000 | — | — | 44,352 | — | |
| Feb 13, 2019 AForm 4 → | Feb 15, 6:15 pm EST | Daniel BradburyChief Executive Officer, Director, 10% Owner | 90,000 | — | — | 90,000 | — |